OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)

NCT05139810 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: Donidalorsen
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.